Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

ATCC and LGC add new customer-driven format to quality control standards portfolio

20 Nov 2014
LGC, as the exclusive distributor of ATCC products in Europe, announces the release of ATCC® Minis to support quality control (QC) testing in pharmaceutical and industrial labs.
 
LGC, an international life sciences measurement and testing company, supplies reference materials to support measurement accuracy and quality control in laboratories worldwide, in a range of sectors including food, environmental, pharmaceutical, forensic, clinical and industrial. ATCC is the premier global biological materials resource and standards organization.
 
LGC’s partnership with ATCC® gives scientists throughout Europe efficient access to ATCC’s biological resources. The ATCC® Minis make it easier for industrial and pharmaceutical labs to test for product safety.
 
Dr. Mindy Goldsborough, ATCC Vice President , said, “Many customers spend considerable time and resources creating cryopreserved stocks from ATCC organisms, acquired either directly from ATCC and our exclusive distributors or through ATCC Licensed Derivative® program partners. With the availability of ATCC® Minis, we now provide our high quality strains in a ready to use mini-cryovial format to meet customers’ requirements. We have created single-use glycerol stocks, so our customers can validate their QC work quickly and efficiently without the risk of cross-contamination during banking techniques.”
 
Healthcare, personal care product, and cosmetic manufacturers are required to test the bio-burden and sterility of their products and production environments to ensure consumer safety. Global alignment and harmonization of microbial testing requirements among the United States Pharmacopeia (USP), Japanese Pharmacopeia (JP), and European Pharmacopeia (EP), have resulted in the need for consistent and reliable control organisms at less than five passages from the ATCC reference stock for reproducible results.